However, in human brain sections the same antibody exposed a significantly lower area fraction of Bral1 immunoreactivity both in the overall WM of the sections and around individual NRs in MDD vs. control subjects (Fig. 6A, bottom panel). The gene discussed is HAPLN2; the disease is major depressive disorder.